Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 6
Submit an article Journal homepage
593
Views
18
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab

Giselle SalmasiDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
,
Michael LiDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
,
Vithika SivabalasundaramDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
,
Tony PanzarellaDepartment of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada
,
Richard TsangDepartment of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, Canada
,
Vishal KukretiDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
,
Michael CrumpDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
&
John KuruvillaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, CanadaCorrespondence[email protected]
 show all
Pages 1659-1664 | Received 27 Apr 2014, Accepted 30 Aug 2014, Published online: 30 Oct 2014

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Hiromichi Yamane, Nobuaki Ochi, Yasunari Nagasaki, Tomoko Yamagishi, Yoshihiro Honda, Nozomu Nakagawa, Masami Takeyama, Hidekazu Nakanishi & Nagio Takigawa. (2018) Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17. Therapeutics and Clinical Risk Management 14, pages 1457-1465.
Read now
Marta Pérez-De-Lis, Soledad Retamozo, Alejandra Flores-Chávez, Belchin Kostov, Roberto Perez-Alvarez, Pilar Brito-Zerón & Manuel Ramos-Casals. (2017) Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry). Expert Opinion on Drug Safety 16:11, pages 1255-1271.
Read now
Hervé Ghesquières. (2015) Pneumonitis following immunochemotherapy with rituximab: a new well-designed retrospective study to better assess the risks. Leukemia & Lymphoma 56:6, pages 1577-1578.
Read now

Articles from other publishers (15)

Dian Jin, Jing Le, Qianqian Yang, Qianqian Cai, Hui Dai, Liufei Luo, Jiaqi Tong & Wenxiu Shu. (2023) Pneumocystis jirovecii with high probability detected in bronchoalveolar lavage fluid of chemotherapy-related interstitial pneumonia in patients with lymphoma using metagenomic next-generation sequencing technology. Infectious Agents and Cancer 18:1.
Crossref
Chunxiao Liu, Xuewu Zhang, Yanan Zhu, Juying Wei, Xingnong Ye, Chunmei Yang, Hongyan Tong, Wenyuan Mai, Min Yang, Jiejing Qian, Liping Mao, Haitao Meng, Jie Jin & Wenjuan Yu. (2023) Trimethoprim-sulfamethoxazole prevents interstitial pneumonitis in B-cell lymphoma patients receiving chemotherapy: a propensity score matching analysis. Annals of Hematology 102:9, pages 2387-2395.
Crossref
Jing Yang, Limin Chai, Junting Jia, Liping Su & Zhiying Hao. (2022) Meta-Analysis of Risk Factors and Incidence of Interstitial Pneumonia With CHOP-Like Regimens for Non-Hodgkin Lymphoma. Frontiers in Oncology 12.
Crossref
Tingting Lu & Guoren Yang. (2021) 18F-FDG PET/CT imaging in the diagnosis of drug-induced lung disease and pulmonary infection in lymphoma. Medicine 100:37, pages e27107.
Crossref
Cong Li, Fangxiao Lu, Tao Lei, Haifeng Yu, Xi Chen, Shuailing Peng, Shuiyun Han & Haiyan Yang. (2020) Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy. BMC Cancer 20:1.
Crossref
Yuxin Sun, Chi Shao, Kai Xu, Ji Li, Ying Zhang, Peng Liu, Hui Huang & Ruie Feng. (2020) Progressive dyspnea and diffuse ground‐glass opacities after treatment for lymphoma with rituximab‐containing chemotherapy: A case report. Thoracic Cancer 11:7, pages 2040-2043.
Crossref
Meixin Zhao & Weifang Zhang. (2018) Early detection value of 18F-FDG-PET/CT for drug-induced lung injury in lymphoma. Annals of Hematology 98:4, pages 909-914.
Crossref
Kimberly Keefer, Regis Bender, Jason Liao, Jeffrey Sivik & Andry Van de Louw. (2018) Characteristics of pulmonary complications in non-Hodgkin’s lymphoma patients treated with rituximab-containing chemotherapy and impact on survival. Annals of Hematology 97:12, pages 2373-2380.
Crossref
Mingxiao Lang, Jingwei Yu, Xianhuo Wang, Zheng Song, Lanfang Li, Lihua Qiu & Huilai Zhang. (2018) Immunochemotherapeutic increase of peripheral absolute monocyte count predicts interstitial pneumonia in lymphoma patients. Hematological Oncology 36:5, pages 779-785.
Crossref
Igor-Wolfgang Blau, Werner J. Heinz, Stefan Schwartz, Hans-Peter Lipp, Philippe Schafhausen & Georg Maschmeyer. (2018) Wichtige Differentialdiagnosen von Lungeninfiltraten bei hämatologischen PatientenPulmonary infiltrates in haematological patients. MMW - Fortschritte der Medizin 160:S4, pages 12-17.
Crossref
Ting Zhou, Qian Shen, Hui Peng, Tengfei Chao, Lihong Zhang, Liu Huang, Kaixiang Yang, Sudip Thapa, Shiying Yu & Yongsheng Jiang. (2017) Incidence of interstitial pneumonitis in non-Hodgkin’s lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab. Annals of Hematology 97:1, pages 141-147.
Crossref
Wei Ping Liu, Xiao Pei Wang, Wen Zheng, Yan Xie, Mei Feng Tu, Ning Jing Lin, Ling Yan Ping, Zhi Tao Ying, Chen Zhang, Li Juan Deng, Ning Ding, Xiao Gan Wang, Yu Qin Song & Jun Zhu. (2017) Incidence, clinical characteristics, and outcome of interstitial pneumonia in patients with lymphoma. Annals of Hematology 97:1, pages 133-139.
Crossref
. (2016) Antineoplastics. Reactions Weekly 1583:1, pages 108-108.
Crossref
N. L. Berinstein, S. Bhella, N. M. Pennell, M. C. Cheung, K. R. Imrie, D. E. Spaner, V. Milliken, L. Zhang, K. Hewitt, A. Boudreau, M. D. Reis, A. Chesney, D. Good, Z. Ghorab, L. K. Hicks, E. Piliotis & R. Buckstein. (2015) Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab. Annals of Hematology 94:5, pages 813-823.
Crossref
Yolanda W. Ng, Manpreet Singh & Minnie M. Sarwal. (2015) Antibody-Mediated Rejection in Pediatric Kidney Transplantation: Pathophysiology, Diagnosis, and Management. Drugs 75:5, pages 455-472.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.